FDA approves Ionis’ TRYNGOLZA for FCS treatment
The decision was influenced by the outcomes of the Phase III Balance trial.
Approvals
FDA approves Mesoblast’s Ryoncil for SR-aGvHD treatment
Egyptian Drug Authority approves Lilly and EVA’s insulin injection
China NMPA approves MSD’s KEYTRUDA for stages of NSCLC
FDA approves Galderma’s Nemluvio to treat atopic dermatitis
China NMPA approves Santhera’s DMD treatment therapy
Sanofi’s combo vaccines gain FDA fast track designation
Priority FDA review given to AstraZeneca’s Imfinzi sBLA for MIBC
